PMDA inspection

Shire Human Genetic Therapies, Inc.(300 SW)

PMDA inspection 5130508010949 · USA · Suitable

Key facts

Control number 5130508010949
Manufacturing site Shire Human Genetic Therapies, Inc.(300 SW)
Location 300 Shire Way, Lexington, MA 02421, USA
Country USA
Product type Pharmaceuticals
Application type Regular
Inspection method On-Site
Inspection month Nov 1, 2023
Result Suitable
Result notified Feb 5, 2024
PMDA registration AG30400352

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)